Pharmacosmos
Pharmacosmos A/S, a leading player in the pharmaceutical industry, is headquartered in Denmark (DK) and operates extensively across Europe and beyond. Founded in 1983, the company has established itself as a specialist in iron deficiency treatment, focusing on innovative therapies that enhance patient care. Pharmacosmos is renowned for its core products, including intravenous iron formulations, which are distinguished by their efficacy and safety profiles. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in the healthcare sector. With a strong market presence and a dedication to improving patient outcomes, Pharmacosmos continues to make notable contributions to the treatment of iron deficiency and related conditions.
DitchCarbon Score
How does Pharmacosmos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmacosmos's score of 18 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmacosmos's reported carbon emissions
Pharmacosmos, headquartered in Denmark (DK), currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined. Without concrete figures or initiatives, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. As the sector increasingly focuses on sustainability, Pharmacosmos may need to establish clear emissions reduction strategies and commitments to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmacosmos is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
